- List
- By Topic
- On Map
- Search Details

FILGRASTIM (1503 records)
Need help? See Downloading Content for Analysis
For Advanced Users: Full Study Record XML Download
1 | NCT01859637 | Terminated Has Results |
Immunogenicity, Safety, and Efficacy of Zarzio®/Filgrastim HEXAL® in Patients With Severe Chronic Neutropenia |
|
|
Interventional |
Phase 4 |
|
Industry |
|
|
6 | All | 18 Years and older (Adult, Older Adult) | NCT01859637 | EP06-401 | July 2011 | March 2014 | September 2015 | May 22, 2013 | March 28, 2016 | March 28, 2016 |
|
||
2 | NCT01933971 | Completed | Evaluation of Dose-response, Pharmacodynamic and Pharmacokinetic Bioequivalence of Filgrastim in Healthy Male Volunteers After Single and Multiple-dose Subcutaneous Administration of the Test Injectable Formulation BK0023 vs. Neupogen® |
|
|
Interventional |
Phase 1 |
|
Industry / Other |
|
|
102 | Male | 20 Years to 40 Years (Adult) | NCT01933971 | CRO-PK-06-175 2007DR1116 |
June 2007 | April 2008 | April 2008 | September 4, 2013 | September 9, 2013 |
|
|||
3 | NCT01713309 | Completed | Heparin Binding Protein in Patients With Acute Respiratory Failure Treated With GCSF (Filgrastim) |
|
|
Interventional |
Phase 2 Phase 3 |
|
Other |
|
|
59 | All | 18 Years and older (Adult, Older Adult) | NCT01713309 | HBP01 | HBP-Neupogen | January 1996 | June 1998 | September 1998 | October 24, 2012 | October 29, 2012 |
|
||
4 | NCT03029000 | Terminated Has Results |
Study of the Effect of a 5-Day Regimen of Study Drug on Peripheral Stem Cell Mobilization in Healthy Participants |
|
|
Interventional |
Phase 3 |
|
Industry |
|
|
1 | All | 18 Years to 60 Years (Adult) | NCT03029000 | TV44688-ONC-30054 | GRANIX | August 2, 2017 | October 30, 2017 | October 30, 2017 | January 23, 2017 | December 14, 2018 | December 14, 2018 |
|
|
5 | NCT02783937 | Unknown † | Filgrastim for Premature Ovarian Insufficiency |
|
|
Interventional |
Phase 4 |
|
Other |
|
|
10 | Female | 16 Years to 40 Years (Child, Adult) | NCT02783937 | OBGYN001 | FIL-POI | November 2016 | December 2017 | June 2018 | May 26, 2016 | November 29, 2016 | |||
6 | NCT02923791 | Completed | A Study in Healthy Volunteers to Assess Immune Response to Multiple Injections of Filgrastim Hospira or Neupogen Reference Product. |
|
|
Interventional |
Phase 1 |
|
Industry |
|
|
256 | All | 18 Years to 65 Years (Adult, Older Adult) | NCT02923791 | C1121012 FILGRASTIM IMMUNOGENICITY US COMPARATIVE IMMUNOGENICITY |
October 2016 | January 2017 | January 2017 | October 5, 2016 | February 23, 2017 |
|
|||
7 | NCT02766634 | Completed | A Research Study To Test How Multiple Doses Of Filgrastim Hospira Works In The Body Of Healthy Study Subjects When Given by Subcutaneous Injection (SC) (Shot) Compared To An Already U.S.-Approved Drug Neupogen® (Amgen) |
|
|
Interventional |
Phase 1 |
|
Industry |
|
|
60 | All | 18 Years to 65 Years (Adult, Older Adult) | NCT02766634 | ZIN-FIL-1501 C1121003 |
March 2016 | June 2016 | June 2016 | May 10, 2016 | July 21, 2016 |
|
|||
8 | NCT02078102 | Recruiting | A Phase II Trial Using Meloxicam Plus Filgrastim in Patients With Multiple Myeloma and Non-Hodgkin's Lymphoma |
|
|
Interventional |
Phase 2 |
|
Other / NIH |
|
|
32 | All | 18 Years and older (Adult, Older Adult) | NCT02078102 | IUCRO-0419 CA182947 1312925163 |
March 11, 2014 | January 1, 2019 | January 1, 2020 | March 5, 2014 | March 14, 2018 |
|
|||
9 | NCT02762799 | Completed Has Results |
Clinical Trial to Evaluate Pharmacokinetics, Pharmacodynamics and Safety of Leucostim® Compared to Neupogen® |
|
|
Interventional |
Phase 1 |
|
Industry |
|
|
60 | Male | 18 Years to 45 Years (Adult) | NCT02762799 | BCD-002-1 | July 18, 2016 | November 11, 2016 | November 11, 2016 | May 5, 2016 | December 18, 2018 | December 18, 2018 | |||
10 | NCT02766647 | Completed | A Research Study To Test How Filgrastim Hospira Works In The Body Of Healthy Study Subjects When Given By Subcutaneous Injection (Shot) Compared To An Already U.S.-Approved Drug Neupogen® (Amgen) |
|
|
Interventional |
Phase 1 |
|
Industry |
|
|
24 | All | 18 Years to 65 Years (Adult, Older Adult) | NCT02766647 | ZIN-FIL-1502 C1121002 |
December 2015 | February 2016 | March 2016 | May 10, 2016 | May 10, 2016 |
|
|||
11 | NCT02190721 | Completed Has Results |
A Study to Evaluate 5 μg/kg Tbo-filgrastim in Infants, Children and Adolescents With Solid Tumors Without Bone Marrow Involvement |
|
|
Interventional |
Phase 2 |
|
Industry |
|
|
50 | All | 1 Month to 16 Years (Child) | NCT02190721 | XM02-ONC-201 2014-001772-55 |
May 12, 2015 | April 4, 2017 | April 4, 2017 | July 15, 2014 | July 31, 2018 | July 31, 2018 |
|
||
12 | NCT03486080 | Enrolling by invitation | Study of Dutogliptin in Combination With Filgrastim in Post-Myocardial Infarction |
|
|
Interventional |
Phase 2 |
|
Industry |
|
|
140 | All | 18 Years to 85 Years (Adult, Older Adult) | NCT03486080 | REC-DUT-002 | December 7, 2018 | December 2019 | March 2020 | April 3, 2018 | February 1, 2019 |
|
|||
13 | NCT01519700 | Completed Has Results |
Phase III Study Comparing the Efficacy and Safety of EP2006 and Filgrastim |
|
|
Interventional |
Phase 3 |
|
Industry |
|
|
218 | Female | 18 Years and older (Adult, Older Adult) | NCT01519700 | EP06-302 2010-024481-22 |
PIONEER | December 2011 | June 2013 | June 2013 | January 27, 2012 | May 6, 2015 | April 7, 2015 |
|
|
14 | NCT00785525 | Recruiting | Filgrastim-Mobilized Stem Cells for Transplantation Using Unrelated Donors |
|
|
Interventional |
Phase 3 |
|
Other |
|
|
40000 | All | 18 Years to 60 Years (Adult) | NCT00785525 | PBSC | February 1997 | January 2022 | January 2022 | November 5, 2008 | June 14, 2017 |
|
|||
15 | NCT02816164 | Recruiting | A Study to Compare Administration Schedules of G-CSF (Filgrastim) for Primary Prophylaxis of Febrile Neutropenia |
|
|
Interventional |
Phase 4 |
|
Other |
|
|
176 | All | 19 Years and older (Adult, Older Adult) | NCT02816164 | OTT 16-04 | REaCT-G2 | September 2016 | December 2019 | December 2020 | June 28, 2016 | March 2, 2018 |
|
||
16 | NCT01987596 | Active, not recruiting | Study of Fixed vs. Flexible Filgrastim to Accelerate Bone Marrow Recovery After Chemotherapy in Children With Cancer |
|
|
Interventional |
Phase 3 |
|
Other / NIH |
|
|
23 | All | 1 Year to 25 Years (Child, Adult) | NCT01987596 | 2013-062 NCI-2013-02001 P30CA022453 |
August 2013 | September 30, 2017 | September 30, 2017 | November 19, 2013 | March 30, 2017 |
|
|||
17 | NCT01285219 | Completed | A Study Comparing Pegylated Filgrastim and Filgrastim in Support for Chemotherapy |
|
|
Interventional |
Phase 3 |
|
Other |
|
|
337 | All | 18 Years to 70 Years (Adult, Older Adult) | NCT01285219 | PEG3 2002SL0047 |
January 2006 | May 2007 | December 2008 | January 27, 2011 | January 27, 2011 | ||||
18 | NCT01238562 | Completed | Safety, Tolerability, Pharmacokinetics and Pharmacodynamics Study of YPEG-Filgrastim in Chemotherapy Patients |
|
|
Interventional |
Phase 1 |
|
Industry / Other |
|
|
30 | All | 18 Years to 70 Years (Adult, Older Adult) | NCT01238562 | TB1004CSF | Filgrastim | April 2010 | November 2011 | November 2011 | November 10, 2010 | February 4, 2013 |
|
||
19 | NCT00115128 | Completed | Open-Label Trial of Peripheral Blood Progenitor Cell (PBPC) Mobilization by Filgrastim in Normal Donors |
|
|
Observational |
|
Industry |
|
|
309 | All | 18 Years and older (Adult, Older Adult) | NCT00115128 | 20020143 | November 2003 | May 2007 | September 2007 | June 22, 2005 | May 13, 2013 | |||||
20 | NCT01541072 | Terminated | Lymphocyte Reconstitution After Administration of Pegfilgrastim Versus Filgrastim After Peripheral Stem Cell Transplantation |
|
|
Interventional |
Not Applicable |
|
Other / Industry |
|
|
34 | All | 18 Years and older (Adult, Older Adult) | NCT01541072 | ET2011-010 2011-A00662-39 |
PALM2 | February 2012 | June 2014 | September 2014 | February 29, 2012 | November 1, 2016 |
|
||
21 | NCT01617577 | Completed Has Results |
Efficacy and Safety of Filgrastim in Alzheimer's Disease |
|
|
Interventional |
Phase 1 Phase 2 |
|
Other |
|
|
8 | All | 55 Years and older (Adult, Older Adult) | NCT01617577 | ADDF-GCSF | FFAD | June 2009 | February 2012 | February 2012 | June 12, 2012 | December 27, 2012 | December 27, 2012 |
|
|
22 | NCT02814110 | Recruiting | Efficacy Safety of Granulocyte Colony-stimulating Factor Treatment Children and Adolescents With Muscular Dystrophy |
|
|
Interventional |
Phase 1 |
|
Other |
|
|
27 | All | 5 Years to 15 Years (Child) | NCT02814110 | UMB 143-20899 P | March 1, 2013 | December 31, 2017 | December 31, 2018 | June 27, 2016 | September 14, 2017 |
|
|||
23 | NCT02225652 | Completed | A Phase II Study of Dose Density Regimen With Fluorouracil, Epirubicin and Cyclophosphamide at Days 1, 4 Every 14 Days With Filgrastim Support Followed by Weekly Paclitaxel in Women With Primary Breast Cancer. |
|
|
Interventional |
Phase 2 |
|
Other |
|
|
11 | Female | 18 Years to 70 Years (Adult, Older Adult) | NCT02225652 | IRST174.05 2010-020772-38 |
September 2010 | September 2013 | July 2014 | August 26, 2014 | August 26, 2014 |
|
|||
24 | NCT01222819 | Terminated | SubCutaneous (SC) Versus Intravenous (IV) Granulocyte Colony Stimulating Factors (G-CSF) for the Treatment of Neutropenia in Hospitalized Haemato-oncological Patients |
|
|
Interventional |
Phase 4 |
|
Other |
|
|
120 | All | 18 Years to 90 Years (Adult, Older Adult) | NCT01222819 | 5981 | G-CSF | January 2011 | December 2012 | April 2013 | October 18, 2010 | April 6, 2016 |
|
||
25 | NCT01766934 | Active, not recruiting | Non-interventional, Long-term Safety Data Collection of Zarzio® / Filgrastim HEXAL® in Stem Cell Donors |
|
Observational |
|
Industry |
|
|
245 | All | 18 Years and older (Adult, Older Adult) | NCT01766934 | EP06-501 | SMART | May 2011 | August 2024 | August 2024 | January 11, 2013 | December 13, 2018 |
|
||||
26 | NCT03549728 | Not yet recruiting | Effect of Granulocyte Colony-stimulating Factor on Clinical Pregnancy Rate in Patients With Endometriosis |
|
|
Interventional |
Phase 2 |
|
Other |
|
|
88 | Female | 20 Years to 40 Years (Adult) | NCT03549728 | 2808 | June 2018 | October 2018 | December 2018 | June 8, 2018 | June 8, 2018 | ||||
27 | NCT02806791 | Unknown † | Efficacy of Biosimilar Filgrastim on the Mobilization of Hematopoietic Stem Cell CD34+ (Cluster of Differentiation 34) and on the Kinetic Engraftment |
|
|
Observational |
|
Other |
|
|
300 | All | Child, Adult, Older Adult | NCT02806791 | BIO-AUTO 06-15 | May 2016 | May 2016 | June 21, 2016 | June 21, 2016 |
|
|||||
28 | NCT01079676 | Completed | A Non-inferiority Study Comparing Two Filgrastim Preparations in Breast Cancer |
|
|
Interventional |
Phase 3 |
|
Industry |
|
|
220 | Female | 18 Years and older (Adult, Older Adult) | NCT01079676 | EF-026 | March 2011 | April 2011 | October 2012 | March 3, 2010 | October 16, 2012 |
|
|||
29 | NCT02098109 | Completed Has Results |
Non-inferiority Study of XM02 Filgrastim (Granix) and Filgrastim (Neupogen) in Combination With Plerixafor for Autologous Stem Cell Mobilization in Patients With Multiple Myeloma or Non-Hodgkin Lymphoma |
|
|
Interventional |
Phase 2 |
|
Other |
|
|
100 | All | 18 Years and older (Adult, Older Adult) | NCT02098109 | 201403068 | August 20, 2014 | June 10, 2016 | September 18, 2016 | March 27, 2014 | July 18, 2017 | July 18, 2017 |
|
||
30 | NCT03317899 | Recruiting | Stem Cell Transplant With or Without Tbo-filgrastim in Treating Patients With Multiple Myeloma or Non-Hodgkin Lymphoma |
|
|
Interventional |
Phase 2 |
|
Other |
|
|
140 | All | 18 Years and older (Adult, Older Adult) | NCT03317899 | 17D.404 | October 12, 2017 | June 2021 | June 2022 | October 23, 2017 | May 24, 2018 |
|
|||
31 | NCT00114764 | Completed | Trial Comparing Pegfilgrastim With Filgrastim as an Adjunct to Chemotherapy for Acute Myeloid Leukaemia (AML) |
|
|
Interventional |
Phase 2 |
|
Industry |
|
|
84 | All | 18 Years and older (Adult, Older Adult) | NCT00114764 | 20020163 | March 2003 | April 2004 | August 2004 | June 20, 2005 | October 31, 2008 | ||||
32 | NCT01899326 | Unknown † | Desipramine Hydrochloride and Filgrastim For Stem Cell Mobilization in Patients With Multiple Myeloma Undergoing Stem Cell Transplant |
|
|
Interventional |
Not Applicable |
|
Other / NIH |
|
|
9 | All | 18 Years to 70 Years (Adult, Older Adult) | NCT01899326 | 2012-230 NCI-2013-01212 11-010 P30CA013330 |
December 2012 | March 2015 | July 15, 2013 | January 12, 2016 |
|
||||
33 | NCT00050674 | Completed | Docetaxel and Gemcitabine With Filgrastim-SD/01 Support in Patients With Advanced Non-Small Cell Lung Carcinoma |
|
|
Interventional |
Phase 2 |
|
Other / Industry |
|
40 | All | 18 Years and older (Adult, Older Adult) | NCT00050674 | SD01-20010120 | November 2001 | February 2007 | February 2007 | December 18, 2002 | December 27, 2012 |
|
||||
34 | NCT01543971 | Completed | Safety and Efficacy of TXA127 and Neupogen to Increase Peripheral Blood Stem Cells (PBSCs) |
|
|
Interventional |
Phase 1 |
|
Industry |
|
|
18 | All | 18 Years to 45 Years (Adult) | NCT01543971 | TXA127-2009-003 | December 2009 | December 2009 | March 2010 | March 5, 2012 | August 31, 2016 |
|
|||
35 | NCT01076270 | Terminated Has Results |
Plerixafor and Filgrastim For Mobilization of Donor Peripheral Blood Stem Cells Before A Donor Peripheral Blood Stem Cell Transplant in Treating Patients With Hematologic Malignancies |
|
|
Interventional |
Not Applicable |
|
Other / NIH |
|
|
1 | All | 18 Years to 65 Years (Adult, Older Adult) | NCT01076270 | 2385.00 NCI-2010-00252 |
June 2010 | January 2011 | February 2011 | February 26, 2010 | June 28, 2017 | March 31, 2017 |
|
||
36 | NCT00410696 | Completed | Pegfilgrastim Versus Filgrastim After High-dose Chemotherapy |
|
|
Interventional |
Phase 2 |
|
Other |
|
|
80 | All | 18 Years and older (Adult, Older Adult) | NCT00410696 | ONC-2006-001 EUDRACT 2006-001409-27 |
September 2006 | November 2008 | November 2008 | December 13, 2006 | July 1, 2013 |
|
|||
37 | NCT02037256 | Active, not recruiting | Bortezomib and Filgrastim in Promoting Stem Cell Mobilization in Patients With Non-Hodgkin Lymphoma or Multiple Myeloma Undergoing Stem Cell Transplant |
|
|
Interventional |
Not Applicable |
|
Other / NIH |
|
|
20 | All | 18 Years to 70 Years (Adult, Older Adult) | NCT02037256 | 2008-134 NCI-2012-01173 P30CA022453 |
July 2011 | June 2017 | June 2017 | January 15, 2014 | May 24, 2017 |
|
|||
38 | NCT02521441 | Completed | A Phase II, Dose-finding Study of F-627 in Patients With Breast Cancer Receiving Myelotoxic Chemotherapy. |
|
|
Interventional |
Phase 2 |
|
Industry / Other |
|
|
138 | Female | 18 Years to 70 Years (Adult, Older Adult) | NCT02521441 | SP-CDR-1-1302 | July 3, 2014 | September 20, 2015 | December 22, 2015 | August 13, 2015 | February 23, 2018 |
|
|||
39 | NCT01719432 | Recruiting | Effect of Body Mass on Filgrastim Pharmacokinetics |
|
Observational |
|
Other |
|
|
30 | All | 18 Years and older (Adult, Older Adult) | NCT01719432 | WVU 021112 | December 5, 2012 | December 2018 | December 2018 | November 1, 2012 | May 30, 2018 |
|
|||||
40 | NCT03323541 | Completed | Use of Zarzio® in Post-autologous Stem Cell Transplantation Procedure |
|
|
Observational |
|
Other |
|
|
62 | All | 18 Years and older (Adult, Older Adult) | NCT03323541 | ZAPA | ZAPA | November 3, 2016 | December 31, 2016 | December 31, 2016 | October 27, 2017 | September 21, 2018 | ||||
41 | NCT02685111 | Recruiting | Intermittent G-CSF in Patients With Breast Cancer Receiving Adjuvant Docetaxel, Doxorubicin, and Cyclophosphamide (TAC) |
|
|
Interventional |
Phase 2 |
|
Other / Industry |
|
|
162 | Female | 19 Years to 70 Years (Adult, Older Adult) | NCT02685111 | AMC 2015-1143 | February 2016 | December 2018 | March 2019 | February 18, 2016 | August 29, 2017 |
|
|||
42 | NCT00207792 | Unknown † | Trial of Filgrastim Versus Placebo Following Allogeneic Bone Marrow Transplantation |
|
|
Interventional |
Phase 3 |
|
Other |
|
160 | All | 16 Years to 45 Years (Child, Adult) | NCT00207792 | GCSF | July 2005 | September 21, 2005 | November 6, 2007 |
|
||||||
43 | NCT00932217 | Unknown † | Study on the Incidence of Febrile Episodes During Stem Cells Collection After Chemotherapy in Patients With Multiple Myeloma |
|
|
Interventional |
Phase 3 |
|
Other |
|
|
180 | All | 18 Years to 70 Years (Adult, Older Adult) | NCT00932217 | Pisa 01 | December 2004 | April 2007 | July 3, 2009 | July 3, 2009 | |||||
44 | NCT03023774 | Completed | Use of Gcsf in Patients With Recurrent Ivf/Icsi Failure |
|
|
Interventional |
Not Applicable |
|
Other |
|
|
20 | Female | up to 36 Years (Child, Adult) | NCT03023774 | ABT-1233-RV | June 2016 | October 2016 | December 2016 | January 18, 2017 | January 18, 2017 | ||||
45 | NCT00038558 | Completed | Prophylactic Use of Filgrastim SD/01 in Patients With Hodgkin's Disease Receiving ABVD Chemotherapy |
|
|
Interventional |
Phase 3 |
|
Other |
|
|
25 | All | 16 Years and older (Child, Adult, Older Adult) | NCT00038558 | ID01-087 | November 2001 | February 2004 | March 2005 | June 3, 2002 | October 31, 2018 |
|
|||
46 | NCT01315470 | Unknown † | Use of Granulocyte Colony-stimulating Factor for the Treatment of Recurrent Implantation Failure in IVF Patients |
|
|
Interventional |
Phase 1 |
|
Other |
|
|
20 | Female | 20 Years to 45 Years (Adult) | NCT01315470 | GCSF-HMO-CTIL | June 2011 | January 2013 | March 2013 | March 15, 2011 | March 24, 2011 |
|
|||
47 | NCT02184897 | Unknown † | Pharmacokinetic and Pharmacodynamic Study of Lenograstim for Hematopoietic Stem Cell Mobilization |
|
|
Interventional |
Not Applicable |
|
Other |
|
|
24 | All | 18 Years to 65 Years (Adult, Older Adult) | NCT02184897 | AMC_MM01 | July 2014 | August 2016 | December 2016 | July 9, 2014 | July 26, 2016 |
|
|||
48 | NCT01266447 | Completed Has Results |
Veliparib, Topotecan Hydrochloride, and Filgrastim or Pegfilgrastim in Treating Patients With Persistent or Recurrent Cervical Cancer |
|
|
Interventional |
Phase 2 |
|
NIH |
|
|
27 | Female | 18 Years and older (Adult, Older Adult) | NCT01266447 | NCI-2011-02659 GOG-0127W CDR0000691281 U10CA180868 U10CA027469 |
February 2011 | January 2016 | January 2016 | December 24, 2010 | July 12, 2017 | February 1, 2017 |
|
||
49 | NCT02931071 | Unknown † | Clinical Phase II Trial to Evaluate CD34+ Cells Mobilization and Collection in Patients With Fanconi Anemia for Subsequent Transduction With a Lentiviral Vector Carring FANCA Gene. FANCOSTEM-1 |
|
|
Interventional |
Phase 2 |
|
Other |
|
|
10 | All | 2 Years to 64 Years (Child, Adult) | NCT02931071 | FANCOSTEM-1 2011-006197-88 |
September 2013 | September 2018 | September 2018 | October 12, 2016 | October 12, 2016 |
|
|||
50 | NCT00809549 | Unknown † | Study to Determine The Effect of a Drug Called Neupogen on Stroke Recovery |
|
|
Interventional |
Phase 1 |
|
Other |
|
|
20 | All | 45 Years to 85 Years (Adult, Older Adult) | NCT00809549 | 2006076-01H | GIST | July 2006 | April 2013 | April 2013 | December 17, 2008 | July 13, 2012 |
|
||
51 | NCT00004055 | Completed | Topotecan, Paclitaxel, and Filgrastim in Treating Patients With Previously Untreated Extensive-Stage Small Cell Lung Cancer |
|
|
Interventional |
Phase 2 |
|
Other / NIH |
|
|
38 | All | 18 Years and older (Adult, Older Adult) | NCT00004055 | NCCTG-982052 CDR0000067251 |
November 1999 | July 2004 | July 2004 | June 3, 2004 | July 13, 2016 |
|
|||
52 | NCT02816112 | Recruiting | Granulocyte-colony Stimulating Factors or Antibiotics for Primary Prophylaxis for Febrile Neutropenia |
|
|
Interventional |
Phase 4 |
|
Other |
|
|
176 | All | 19 Years and older (Adult, Older Adult) | NCT02816112 | OTT 16-03 | REaCT-TC2 | September 2016 | August 2019 | August 2020 | June 28, 2016 | March 2, 2018 |
|
||
53 | NCT00002501 | Completed | Cyclophosphamide and Filgrastim in Treating Patients With Stage IV, Relapsed, or Refractory Low-Grade Follicular Non-Hodgkin's Lymphoma |
|
|
Interventional |
Phase 2 |
|
Other / NIH |
|
|
29 | All | 18 Years to 55 Years (Adult) | NCT00002501 | CALGB-9150 CLB-9150 CDR0000077861 |
October 1992 | July 2001 | January 2006 | April 22, 2004 | July 1, 2016 |
|
|||
54 | NCT01569087 | Completed Has Results |
Dose-finding Study of Empegfilgrastim for Neutropenia Prophylaxis in Patients With Breast Cancer |
|
|
Interventional |
Phase 2 |
|
Industry |
|
|
60 | Female | 18 Years to 70 Years (Adult, Older Adult) | NCT01569087 | BCD-017-2 | May 2012 | January 2013 | February 2013 | April 2, 2012 | December 5, 2016 | October 24, 2016 |
|
||
55 | NCT01908621 | Completed | Randomized Trial of G-CSF Alone Versus Intermediate-dose Ara-C Plus G-CSF Mobilization in Multiple Myeloma Patients. |
|
|
Interventional |
Phase 3 |
|
Other |
|
|
90 | All | 18 Years to 65 Years (Adult, Older Adult) | NCT01908621 | MMMobil-COI-01 | March 20, 2013 | March 18, 2016 | October 27, 2017 | July 25, 2013 | August 28, 2018 |
|
|||
56 | NCT01408043 | Terminated | Etoposide, Filgrastim, and Plerixafor in Improving Stem Cell Mobilization in Treating Patients With Non-Hodgkin Lymphoma |
|
|
Interventional |
Not Applicable |
|
Other / NIH |
|
|
25 | All | 18 Years to 78 Years (Adult, Older Adult) | NCT01408043 | CASE2410 NCI-2011-01281 P30CA043703 |
October 2011 | May 2016 | May 2016 | August 3, 2011 | December 7, 2016 |
|
|||
57 | NCT00001071 | Completed | A Study of Stem Cells and Filgrastim |
|
|
Interventional |
Not Applicable |
|
NIH |
|
24 | All | 18 Years and older (Adult, Older Adult) | NCT00001071 | ACTG 285 11261 |
October 1998 | August 31, 2001 | May 23, 2012 |
|
||||||
58 | NCT00596479 | Completed | Filgrastim for the Promotion of Collateral Growth in Patients With CAD |
|
|
Interventional |
Not Applicable |
|
Other |
|
|
50 | All | 18 Years to 90 Years (Adult, Older Adult) | NCT00596479 | 05/04 | November 2004 | December 2007 | December 2007 | January 17, 2008 | June 16, 2015 |
|
|||
59 | NCT02112045 | Active, not recruiting Has Results |
A Study of Granix to Disrupt the Bone Marrow Microenvironment in Patients With Multiple Myeloma Undergoing Autologous Transplantation |
|
|
Interventional |
Phase 2 |
|
Other |
|
|
90 | All | 18 Years and older (Adult, Older Adult) | NCT02112045 | 201405057 | January 20, 2015 | December 13, 2017 | September 5, 2019 | April 11, 2014 | January 7, 2019 | January 7, 2019 |
|
||
60 | NCT00002126 | Completed | A Randomized, Controlled, Multicenter Trial of Filgrastim (Recombinant-Methionyl Human Granulocyte Colony Stimulating Factor; G-CSF) for the Prevention of Grade 4 Neutropenia in Patients With HIV Infection. |
|
|
Interventional |
Phase 2 |
|
Industry |
|
250 | All | 13 Years and older (Child, Adult, Older Adult) | NCT00002126 | 087A GCSF-930101 |
August 31, 2001 | June 24, 2005 |
|
|||||||
61 | NCT02104830 | Completed Has Results |
Study of the Efficacy and Safety of Empegfilgrastim for Neutropenia Prophylaxis in Breast Cancer Patients |
|
|
Interventional |
Phase 3 |
|
Industry |
|
|
135 | Female | 18 Years to 70 Years (Adult, Older Adult) | NCT02104830 | BCD-017-3 | September 2013 | June 2014 | October 2014 | April 4, 2014 | October 24, 2016 | October 24, 2016 |
|
||
62 | NCT01149096 | Terminated | Collection of Bone Marrow From Donors Treated With or Without Filgrastim |
|
|
Observational |
|
Other / NIH |
|
|
13 | All | Child, Adult, Older Adult | NCT01149096 | ASCT0631D NCI-2011-02237 COG-ASCT0631D U10CA098543 |
June 2010 | December 2011 | December 2011 | June 23, 2010 | February 9, 2017 |
|
||||
63 | NCT00215124 | Completed | A Phase I - II Safety Study of Filgrastim (Neupogen) to Improve Left Ventricular Function After Severe Acute Myocardial Infarction |
|
|
Interventional |
Phase 1 Phase 2 |
|
Other |
|
|
All | 18 Years and older (Adult, Older Adult) | NCT00215124 | 5225 | February 2007 | September 22, 2005 | September 19, 2008 |
|
||||||
64 | NCT01946152 | Active, not recruiting | Pomalidomide, Dexamethasone, and Filgrastim in Treating Patients With Relapsed or Refractory Multiple Myeloma |
|
|
Interventional |
Phase 1 Phase 2 |
|
Other / NIH |
|
|
55 | All | 18 Years and older (Adult, Older Adult) | NCT01946152 | 2013-0018 NCI-2014-01270 NCI-2014-00159 P30CA016672 |
March 5, 2014 | March 1, 2021 | March 1, 2021 | September 19, 2013 | November 21, 2018 |
|
|||
65 | NCT00003929 | Withdrawn | Chemotherapy, Filgrastim, and Radiation Therapy in Treating Patients With Primary Central Nervous System Lymphoma |
|
|
Interventional |
Phase 2 |
|
Other / NIH |
|
|
0 | All | Child, Adult, Older Adult | NCT00003929 | CWRU3496 P30CA043703 CWRU-3496 CWRU-AMC-2A-93 NCI-G99-1533 |
June 1998 | March 2000 | July 26, 2004 | March 20, 2012 |
|
||||
66 | NCT00041067 | Completed Has Results |
S0215 Trastuzumab, Docetaxel, Vinorelbine, and Filgrastim in Treating Women With Stage IV Breast Cancer |
|
|
Interventional |
Phase 2 |
|
Other / NIH |
|
|
76 | Female | 18 Years and older (Adult, Older Adult) | NCT00041067 | CDR0000069440 S0215 U10CA032102 |
September 2002 | January 2008 | January 2012 | January 27, 2003 | June 6, 2013 | June 6, 2013 |
|
||
67 | NCT02725086 | Completed | Evaluation of Pharmacokinetic/Pharmacodynamic Properties and Safety of Leucostim® Compared to Neupogen® in Healthy Adult Volunteers |
|
|
Interventional |
Phase 1 |
|
Industry |
|
|
56 | Male | 19 Years to 45 Years (Adult) | NCT02725086 | DA3030_NP_I | February 2016 | April 2016 | May 2016 | March 31, 2016 | November 10, 2016 |
|
|||
68 | NCT01016795 | Terminated | Stem Cell Factor (SCF) Priming of Haematopoietic Stem Cell Grafts in Malignant Lymphoma |
|
|
Interventional |
Phase 2 |
|
Other / Industry |
|
|
32 | All | 18 Years to 65 Years (Adult, Older Adult) | NCT01016795 | SCF 980266 H-KA-99040-GMS |
SCF980266 | January 1999 | November 2000 | November 2009 | November 20, 2009 | June 25, 2015 |
|
||
69 | NCT00004853 | Completed | Comparison of Filgrastim and Filgrastim SD/01in Boosting White Cell Counts After Intensive Chemotherapy |
|
|
Interventional |
Phase 1 |
|
NIH |
|
|
34 | All | up to 25 Years (Child, Adult) | NCT00004853 | 000092 00-C-0092 |
March 3, 2000 | May 20, 2009 | May 20, 2009 | March 6, 2000 | February 5, 2019 |
|
|||
70 | NCT02703051 | Completed | A Study to Evaluate the PK, Safety and Tolerability of GMI-1271 With and Without Filgrastim in Healthy Adult Subjects |
|
|
Interventional |
Phase 1 |
|
Industry |
|
|
54 | All | 19 Years to 60 Years (Adult) | NCT02703051 | GMI-1271-103 | November 2015 | August 2016 | August 2016 | March 9, 2016 | February 27, 2018 |
|
|||
71 | NCT03740464 | Recruiting | Long-acting G-CSF for Febrile Neutropenia |
|
|
Interventional |
Phase 3 |
|
Other |
|
|
556 | Female | 18 Years and older (Adult, Older Adult) | NCT03740464 | EOC-GCSF | November 10, 2018 | November 10, 2019 | November 10, 2023 | November 14, 2018 | November 14, 2018 |
|
|||
72 | NCT02408991 | Withdrawn | Use Art-assist and Neupogen to Treat Chronic Limb Ischemia |
|
|
Interventional |
Phase 4 |
|
Other |
|
|
0 | All | 40 Years to 85 Years (Adult, Older Adult) | NCT02408991 | IRB14-0553 | September 2014 | July 2015 | July 2015 | April 6, 2015 | April 8, 2016 |
|
|||
73 | NCT02331745 | Unknown † | RCT Study on Granulocyte Colony-stimulating Factor(G-CSF) Treatment of Hepatic Failure |
|
|
Interventional |
Phase 4 |
|
Other |
|
|
140 | All | 17 Years to 70 Years (Child, Adult, Older Adult) | NCT02331745 | Z131107002213157 | October 2013 | April 2016 | October 2016 | January 6, 2015 | August 5, 2016 |
|
|||
74 | NCT01194934 | Completed | NOX-A12 Multiple Ascending Dose Study in Healthy Volunteers |
|
|
Interventional |
Phase 1 |
|
Industry |
|
|
12 | All | 18 Years to 55 Years (Adult) | NCT01194934 | SNOXA12C101 2010-020937-14 |
SNOXA12C101 | August 2010 | January 2011 | January 2011 | September 3, 2010 | June 26, 2014 |
|
||
75 | NCT01455025 | Terminated | Study in Plerixafor and Granulocyte-colony Stimulating Factor Patients With Relapse Acute Myeloid Leukemia |
|
|
Interventional |
Phase 1 |
|
Other / Industry |
|
|
11 | All | 18 Years to 65 Years (Adult, Older Adult) | NCT01455025 | Primal study | PRIMAL | January 2012 | March 2015 | August 2015 | October 19, 2011 | March 16, 2016 |
|
||
76 | NCT00901381 | Completed | Granulocyte-colony Stimulating Factor for Stem Cells Therapy for Acute Ischemic Stroke |
|
|
Interventional |
Phase 2 |
|
Other |
|
|
20 | All | 40 Years to 70 Years (Adult, Older Adult) | NCT00901381 | GKSF-8 | STEMTHER | June 2007 | February 2009 | February 2009 | May 13, 2009 | January 7, 2014 |
|
||
77 | NCT03395028 | Enrolling by invitation | GCSF Adjunct Therapy for Biliary Atresia |
|
|
Interventional |
Early Phase 1 |
|
Other |
|
|
6 | All | up to 180 Days (Child) | NCT03395028 | CR00005169 IND 119679-0007 |
BA_GCSF | January 15, 2018 | December 31, 2018 | January 31, 2019 | January 9, 2018 | February 21, 2018 |
|
||
78 | NCT00030758 | Unknown † | Filgrastim or Pegfilgrastim in Preventing Neutropenia in Women Receiving Chemotherapy Following Surgery for Breast Cancer |
|
|
Interventional |
Phase 4 |
|
Other |
|
|
816 | Female | 18 Years and older (Adult, Older Adult) | NCT00030758 | ACCOG-SCTN-BR0101 CDR0000069195 SCTN-BR0101 EU-20143 |
October 2001 | January 27, 2003 | August 7, 2013 |
|
|||||
79 | NCT02722733 | Unknown † | Randomized Trial of G-CSF Alone Versus Intermediate-dose Ara-C Plus G-CSF Mobilization in Hodgkin's Lymphoma or Non-Hodgkin's Lymphoma |
|
|
Interventional |
Phase 3 |
|
Other |
|
|
90 | All | 18 Years to 65 Years (Adult, Older Adult) | NCT02722733 | HL/NHLMobil-COI-01 | March 2016 | March 2017 | April 2017 | March 30, 2016 | March 30, 2016 |
|
|||
80 | NCT00801489 | Recruiting | Fludarabine Phosphate, Cytarabine, Filgrastim-sndz, Gemtuzumab Ozogamicin, and Idarubicin Hydrochloride in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndrome |
|
|
Interventional |
Phase 2 |
|
Other / NIH |
|
|
200 | All | 18 Years and older (Adult, Older Adult) | NCT00801489 | 2007-0147 NCI-2012-01659 P30CA016672 |
April 4, 2007 | April 30, 2020 | April 30, 2020 | December 3, 2008 | November 12, 2018 |
|
|||
81 | NCT03381599 | Active, not recruiting | Stem Cells After Peripheral Mobilization and Harvest |
|
|
Interventional |
Phase 1 |
|
Other / Industry |
|
|
10 | Male | 19 Years to 39 Years (Adult) | NCT03381599 | 16398 | March 28, 2018 | May 2019 | December 2019 | December 22, 2017 | January 9, 2019 |
|
|||
82 | NCT00015938 | Completed | S0102: Docetaxel, Vinorelbine, and Filgrastim in Treating Women With Stage IV Breast Cancer |
|
|
Interventional |
Phase 2 |
|
Other / NIH |
|
95 | Female | 18 Years and older (Adult, Older Adult) | NCT00015938 | CDR0000068575 S0102 U10CA032102 |
May 2001 | February 2005 | November 2012 | January 27, 2003 | January 24, 2013 |
|
||||
83 | NCT00306111 | Completed | Pegfilgrastim vs. Filgrastim - Comparison of Mobilized Blood Stem Cells in Patients With Non Hodgkin-lymphoma |
|
|
Interventional |
Phase 2 |
|
Other |
|
|
14 | All | 18 Years and older (Adult, Older Adult) | NCT00306111 | rpm_001 | January 2006 | December 2008 | December 2011 | March 22, 2006 | May 29, 2014 |
|
|||
84 | NCT00117455 | Completed | A Study of Peripheral Blood Progenitor Cell (PBPC) Mobilisation by Chemotherapy With Pegfilgrastim or Filgrastim in Subjects With Non-Hodgkin's Lymphoma |
|
|
Interventional |
Phase 2 |
|
Industry |
|
|
All | 18 Years and older (Adult, Older Adult) | NCT00117455 | 20020113 | July 7, 2005 | May 16, 2008 | ||||||||
85 | NCT03498248 | Recruiting | Efficacy of Granulocyte-Colony Stimulating Factor (G-CSF) |
|
|
Interventional |
Not Applicable |
|
Other |
|
|
155 | All | Child, Adult, Older Adult | NCT03498248 | Granulocyte-Colony Stimulating | February 19, 2018 | August 31, 2018 | August 31, 2019 | April 13, 2018 | April 13, 2018 |
|
|||
86 | NCT03823950 | Recruiting New |
Starting Granulocyte Colony-Stimulating Factor at 1 Day vs 3 Days Following Chemotherapy in Pediatric Cancer Patients |
|
|
Interventional |
Phase 4 |
|
Other |
|
|
150 | All | up to 21 Years (Child, Adult) | NCT03823950 | 2018-0082 | February 1, 2019 | December 2019 | December 2019 | January 31, 2019 | February 11, 2019 |
|
|||
87 | NCT01182675 | Terminated Has Results |
Hematopoietic Stem Cell Transplantation (HSCT) for Children With SCID Utilizing Alemtuzumab, Plerixafor & Filgrastim |
|
|
Interventional |
Phase 2 |
|
Other |
|
|
7 | All | up to 3 Years (Child) | NCT01182675 | UCSF10-00701 | August 2010 | September 2013 | September 2013 | August 17, 2010 | July 31, 2018 | November 10, 2014 |
|
||
88 | NCT02802852 | Unknown † | Proteomics and Stem Cell Therapy as a New Vascularization Strategy |
|
|
Interventional |
Not Applicable |
|
Other |
|
|
25 | All | 35 Years to 85 Years (Adult, Older Adult) | NCT02802852 | 2015-1244 | June 2016 | March 2017 | March 2017 | June 16, 2016 | June 16, 2016 |
|
|||
89 | NCT01549301 | Completed | Evaluation of Pharmacokinetic and Pharmacodynamic Parameters of Filgrastim (G-CSF)Produced by Blausiegel Indústria e Comércio Ltda. Compared to Granulokine Produced by Produtos Roche Químicos e Farmacêuticos S/A. |
|
|
Interventional |
Phase 1 |
|
Industry |
|
|
128 | All | 18 Years to 50 Years (Adult) | NCT01549301 | FILBLA1211I Version 01 - 09/12/2011 |
August 2012 | August 2013 | September 2013 | March 9, 2012 | June 20, 2018 |
|
|||
90 | NCT02428114 | Completed | A Multi Centre Study to Determine the Feasibility of Using an Integrated Consent Model to Compare Standard of Care Administration Schedules of G-CSF (Filgrastim) for Primary Prophylaxis of Chemotherapy-Induced Febrile Neutropenia in Early Stage Breast Cancer (React-G Study) |
|
Observational |
|
Other |
|
|
142 | All | 19 Years and older (Adult, Older Adult) | NCT02428114 | OTT 14-05 | React-G | May 2015 | March 2017 | March 2017 | April 28, 2015 | September 29, 2017 |
|
||||
91 | NCT00820976 | Completed | Induction With or Without Granulocyte Colony-Stimulating Factor in AML Transplantation in AML |
|
|
Interventional |
Phase 3 |
|
Other |
|
|
260 | All | 16 Years and older (Child, Adult, Older Adult) | NCT00820976 | TLG-AML-95-002 | TLG-AML-95-002 | March 1996 | March 2000 | January 2009 | January 12, 2009 | January 12, 2009 | |||
92 | NCT00511550 | Completed | Filgrastim-Mobilized Peripheral Blood Stem Cells for Allogeneic Transplantation With Unrelated Donors |
|
Observational |
|
Other |
|
15 | All | 18 Years to 60 Years (Adult) | NCT00511550 | UC-2508 | August 2005 | November 2007 | August 6, 2007 | March 5, 2008 |
|
|||||||
93 | NCT02044796 | Active, not recruiting | Filgrastim, Cladribine, Cytarabine, and Mitoxantrone Hydrochloride in Treating Patients With Newly Diagnosed or Relapsed/Refractory Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndromes |
|
|
Interventional |
Phase 1 Phase 2 |
|
Other / NIH |
|
|
199 | All | 18 Years and older (Adult, Older Adult) | NCT02044796 | 2734.00 NCI-2013-02465 P30CA015704 |
January 23, 2014 | March 9, 2018 | August 1, 2022 | January 24, 2014 | May 30, 2018 |
|
|||
94 | NCT00002836 | Completed | Filgrastim Plus Chemotherapy Compared With Filgrastim Alone In Treating Women Undergoing Peripheral Stem Cell Transplantation For Breast Cancer |
|
|
Interventional |
Phase 3 |
|
Other / NIH |
|
|
184 | All | 18 Years to 65 Years (Adult, Older Adult) | NCT00002836 | DM95-047 P30CA016672 MDA-DM-95047 NCI-G96-1014 CDR0000065048 |
September 26, 1995 | March 9, 2006 | March 9, 2006 | November 24, 2003 | November 6, 2018 |
|
|||
95 | NCT00028925 | Completed | Combination Chemotherapy With or Without Filgrastim in Treating Patients With Previously Untreated Extensive-Stage Small Cell Lung Cancer |
|
|
Interventional |
Phase 2 |
|
Other / NIH |
|
|
27 | All | 18 Years and older (Adult, Older Adult) | NCT00028925 | NCCTG-N0027 NCI-2012-02441 CDR0000069147 |
November 2001 | November 2005 | August 2008 | June 30, 2003 | December 7, 2016 |
|
|||
96 | NCT02669680 | Recruiting | Granulocyte Colony Stimulating Factor (G-CSF) to Treat Acute-on-chronic Liver Failure |
|
|
Interventional |
Not Applicable |
|
Other |
|
|
292 | All | 18 Years and older (Adult, Older Adult) | NCT02669680 | GRAFT | February 2016 | March 2020 | March 2020 | February 1, 2016 | October 15, 2018 |
|
|||
97 | NCT00959777 | Completed | Pharmacokinetic/Pharmacodynamic (PK/PD) Study Evaluating DA-3031 (PEG-G-CSF) to Filgrastim (Dong-A) in Healthy Volunteers |
|
|
Interventional |
Phase 1 |
|
Industry | Male | 20 Years to 40 Years (Adult) | NCT00959777 | DA3031_NP_I | August 17, 2009 | October 1, 2014 |
|
|||||||||
98 | NCT01459653 | Completed Has Results |
Multi-level Evaluation of Chemotherapy-induced Febrile Neutropenia Prophylaxis, Outcomes, and Determinants With Granulocyte-colony Stimulating Factor |
|
Observational |
|
Industry |
|
|
1496 | All | 18 Years and older (Adult, Older Adult) | NCT01459653 | EP06-502 | Monitor-GCSF | March 2010 | August 2013 | August 2013 | October 25, 2011 | January 11, 2016 | July 7, 2015 |
|
|||
99 | NCT00005958 | Unknown † | Combination Chemotherapy Plus Filgrastim in Treating Patients With Locally Recurrent or Advanced Urothelium Cancer |
|
|
Interventional |
Phase 2 |
|
Industry |
|
All | 18 Years and older (Adult, Older Adult) | NCT00005958 | CDR0000067939 AMGEN-GCSF-990125 NCI-V00-1594 |
October 1999 | April 20, 2004 | December 4, 2013 |
|
|||||||
100 | NCT01538862 | Completed Has Results |
Efficacy of Granulocyte Colony Stimulating Factor (GCSF) In Patients With Dystrophic Epidermolysis Bullosa |
|
|
Interventional |
Phase 2 |
|
Other |
|
|
7 | All | Child, Adult, Older Adult | NCT01538862 | VICCNCPED1210 | February 2012 | October 2014 | November 2014 | February 24, 2012 | June 23, 2017 | April 25, 2017 |
|
† Study has passed its completion date and status has not been verified in more than two years.